American Vanguard (AVD) Form 4: 17,621 DSUs Granted to Director
Rhea-AI Filing Summary
American Vanguard Corporation director Steven D. Macicek was awarded 17,621 deferred stock units (DSUs) on 08/07/2025 as part of the companys non-management director compensation program tied to the 2025 annual stockholders meeting. Each DSU represents the right to receive one share of common stock upon settlement.
The DSUs were granted at $0, are nontransferable during the recipients service, and carry no voting or dividend rights until settlement. Following the award the reporting persons beneficial ownership is reported as 48,839 shares.
Positive
- 17,621 DSUs awarded to the reporting director as explicit non-management director compensation
- Each DSU equals one share upon settlement, as stated in the filing
- Beneficial ownership reported at 48,839 shares following the award
Negative
- DSUs are nontransferable during the remaining term of service
- DSUs carry no voting or dividend rights until they are settled into shares
Insights
TL;DR: Routine director equity award; increases reported beneficial ownership but confers no immediate voting or dividend rights.
The reported Form 4 documents a director compensation award consistent with standard non-management director DSU programs. The award of 17,621 DSUs is explicitly described as converting to one share per DSU upon settlement and is nontransferable during service. For governance analysis, the key points are the lack of voting and dividend rights while the director remains in service and the explicit terms tying settlement to termination of service.
TL;DR: Non-cash equity grant increases reported stake to 48,839 shares; award recorded at $0 and will settle into common shares later.
From a securities perspective, the Form 4 shows an acquisition of DSUs rather than a cash purchase. The filing lists a $0 grant price and identifies that each DSU entitles the holder to one share upon settlement. The immediate reported beneficial ownership after the award is 48,839 shares. The disclosure is straightforward and appears to be a routine compensation-related disclosure with no other transactions or derivative positions reported.